Increased expression of IGF-1R has been reported in various cancers, including Ewing sarcoma, breast cancer, prostate cancer, pancreatic cancer, melanoma, and other tumor types, contributing to faster tumor progression and, in some cases, poor prognosis [229,230,231]. The gene discussed is IGF1R; the disease is neoplasm.